HMN Placing Results Neutral

HAMMERSON PLC - Results of placing

Hammerson Plc
Full analysis

What this filing means

Hammerson has closed its £189m equity placing at 355p per share (3.8% discount), raising gross proceeds of £189m and net proceeds of £185m to part-fund the acquisition of a 50% stake in Manchester Arndale. The placing, retail offer and director subscription together represent approximately 10% dilution of existing share capital. Three directors subscribed £230k at the placing price and SARB has approved the JSE inward listing. The terms are clean and the demand absorbed the full size without meaningful slippage, but the placing was announced earlier the same day, so the market had already begun processing the transaction.

Hammerson sold new shares to raise £189m — roughly 10% more shares than existed before, which dilutes the value of existing shares. The money funds buying half of Manchester Arndale shopping centre. The discount to the prevailing share price (3.8%) is modest, and the market appears to have absorbed the full size without complaint. Directors also put in £230k, which signals some alignment, though it is a small amount against the total raise. The filing is informational rather than a surprise — the placing was announced earlier the same day.

Bull case

  • CEO cites 'strong support received' for the £189m raise, and the modest 3.8% placing discount indicates demand absorbed the full size at disciplined pricing.
  • CEO Wilkinson, CFO Raja and a non-executive director subscribed personally, aligning senior management with shareholders at the placing price.
  • SARB Financial Surveillance approval secured, confirming the JSE inward listing of new shares and preserving dual-listing access for SA investors.
  • Net proceeds part-fund the strategic acquisition of a 50% stake in Manchester Arndale, enhancing portfolio quality and scale.

Bear case

  • Aggregate issuance of 53,163,160 New Ordinary Shares at a 3.8% discount represents c.10% dilution, structurally transferring value from non-participating holders to placees.
  • Proceeds will 'part-fund' the Manchester Arndale 50% interest but the filing discloses neither the purchase price, implied NOI yield, nor pro-forma LTV, leaving accretion unassessable.
  • Directors subscribed only c.£230k against a £189m raise — token insider commitment that reads as ritualistic rather than a conviction signal at this scale.
  • The placing is explicitly non-pre-emptive, bypassing Pre-Emption Group rights and concentrating allocation discretion with management and the banks.
View original SENS announcement

AI-generated summary by SENS-AI, based on the original JSE SENS filing.

SENS-AI conclusion

The placing is a clean execution of a capital raise the market was processing in real time. The 3.8% discount is tight for a 10% non-pre-emptive issuance, the banks achieved full subscription, and the CEO characterised demand as strong — constructive signals about how the transaction was received. However, the placing was announced earlier on the same day, so the pricing terms were not a market surprise. The 10% dilution is a real structural cost to non-participating holders, and the filing discloses neither the Manchester Arndale purchase price nor the implied NOI yield or pro-forma LTV, leaving the accretion case unassessable. So what: the financing is secured and the acquisition can proceed, but the market still needs the full acquisition announcement to evaluate whether the price paid for the Manchester Arndale stake makes the dilution worthwhile.

The full Manchester Arndale acquisition disclosure is where the market will test whether the price paid justifies the 10% dilution.

Evidence from the filing

  • CEO cites 'strong support received' for the £189m raise, and the modest 3.8% placing discount indicates demand absorbed the full size at disciplined pricing.

    “raising £189 million”
  • CEO Wilkinson, CFO Raja and a non-executive director subscribed personally, aligning senior management with shareholders at the placing price.

    “The following directors of the Company have subscribed for the following number of Subscription Shares at the Placing Price as part of the Subscription: Rob Wilkinson 28,169, Himanshu Raja 28,169, Habib Annous 7,880”
  • SARB Financial Surveillance approval secured, confirming the JSE inward listing of new shares and preserving dual-listing access for SA investors.

    “Hammerson is pleased to announce that the Financial Surveillance Department of the South African Reserve Bank has given its requisite approval to inward list all of the New Ordinary Shares on the Main Board of the securities exchange operated by the JSE Limited ("JSE")”
  • Net proceeds part-fund the strategic acquisition of a 50% stake in Manchester Arndale, enhancing portfolio quality and scale.

    “The net proceeds of the Placing, Retail Offer and Subscription will be used to part-fund a portion of the consideration for the proposed acquisition by the Group of a 50% interest in Manchester Arndale and other transaction-related costs”
  • Aggregate issuance of 53,163,160 New Ordinary Shares at a 3.8% discount represents c.10% dilution, structurally transferring value from non-participating holders to placees.

    “The Placing Shares, the Retail Offer Shares and the Subscription Shares amount, in aggregate, to 53,163,160 new Ordinary Shares (together, the "New Ordinary Shares"), representing c.10% of the existing issued share capital of the Company”
  • Directors subscribed only c.£230k against a £189m raise — token insider commitment that reads as ritualistic rather than a conviction signal at this scale.

    “representing c. £230k in aggregate”
Category
Placing Results
Event posture
Constructive
Published
Jul 30, 2026

More on Hammerson Plc

Related filings